Chemomab Therapeutics Ltd DRC (NYSE: CMMB) — Healthcare · Share Price, Chart & Market Data
About: Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases. Its lead product candidate is nebokitug, a humanized monoclonal antibody that attenuates the basic function of CCL24 as a regulator of major inflammatory and fibrotic pathways, which has completed phase 2 clinical trial for treating primary sclerosing cholangitis, as well as in phase 2 clinical trial to treat systemic sclerosis. The company was founded in 2011 and is based in Tel Aviv-Yafo, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.61 (-0.62%)
CMMBChemomab Therapeutics Ltd DRC
Loading watchlist status…
Trade CMMB now
Chemomab Therapeutics Ltd DRC share price
CMMB price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 12:37 pm GMT+0
CMMB price performance
-2.954%
5D
10.274%
1M
-10.056%
YTD
-69.963%
1Y
CMMB price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 12:37 pm GMT+0
CMMB details
CMMB Market Signals